Paliperidone Tablet, Extended Release
Product Images NDC 72658-1255

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 72658-1255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eskayef Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of paliperidone, depicting its molecular arrangement with nitrogen, oxygen, carbon, fluorine atoms, and characteristic rings.*

FDA Label Image

Principal Display Panel (1.5 mg Tablet Bottle Label)

The image shows a packaging label for Paliperidone Extended-Release Tablets, 1.5 mg strength. The label indicates the product is manufactured by Eskayef Pharmaceuticals Limited in Bangladesh. It includes instructions that tablets should be swallowed whole and not divided, crushed, or chewed. The package contains 30 tablets and is marked Rx only. Storage temperature and handling instructions are also noted.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Label for Paliperidone extended-release tablets, 3 mg strength, manufactured by Eskayef Pharmaceuticals Limited. The label indicates a package size of 100 tablets, with instructions that tablets should be swallowed whole and not divided, crushed, or chewed. Storage and dispensing information is also included along with a barcode and revision date of 11/2024.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Paliperidone 3 mg Extended-Release Tablets label from Eskayef Pharmaceuticals Limited. The label indicates it contains 30 tablets, with directions to swallow whole and not to divide, crush, or chew. Storage conditions and prescription-only status are noted. It includes manufacturer contact details and a barcode.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Paliperidone Extended-Release Tablets 3 mg oral medication label from Eskayef Pharmaceuticals Limited. The label includes dosage strength in green, a 500 tablet package size, and storage instructions. It features a barcode, NDC number 72658-1254-3, and cautions against dividing, crushing, or chewing the tablets.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Label for Paliperidone extended-release tablets, 6 mg strength, orally administered. The label indicates a package size of 100 tablets and is manufactured by Eskayef Pharmaceuticals Limited, Bangladesh. It includes directions to swallow tablets whole and storage temperature instructions. The label shows the NDC number 72658-1255-2 and has a barcode on the right side.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Paliperidone 6 mg Extended-Release Tablets label from Eskayef Pharmaceuticals Limited. The label indicates the product is a prescription oral tablet with 30 tablets per package. Instructions note tablets should be swallowed whole and dispensed in a tight container. The label includes storage temperatures, barcode, and manufacturing details.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Label for Paliperidone Extended-Release Tablets 6 mg by Eskayef Pharmaceuticals Limited. The label indicates a package of 500 tablets with instructions that tablets should be swallowed whole without dividing, crushing, or chewing. It includes storage temperature guidelines and a barcode, with NDC 72658-1255-3.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Label)

Label for Paliperidone Extended-Release Tablets 9 mg by Eskayef Pharmaceuticals Limited. The label includes dosage form, strength, and directions stating tablets should be swallowed whole and not divided, crushed, or chewed. The package contains 100 tablets and is marked Rx only. Storage instructions and a barcode are also visible.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Label)

Label for Paliperidone extended-release tablets, 9 mg strength, manufactured by Eskayef Pharmaceuticals Limited. The label states the tablets should be swallowed whole and come in a package of 30 tablets. Storage and handling instructions, barcode, and manufacturer address in Bangladesh are included on the label.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Label)

Packaging label for Paliperidone 9 mg extended-release tablets. The label shows the product name, strength, and extended-release formulation. It states the package contains 500 tablets and indicates the manufacturer as Eskayef Pharmaceuticals Limited. Additional text includes instructions to swallow tablets whole and storage conditions. The NDC number is 72658-1256-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.